No connection

Search Results

ITOC vs LLY

ITOC
iTonic Holdings Ltd.
BEARISH
Price
$0.28
Market Cap
$6.9M
Sector
Healthcare
AI Confidence
95%
LLY
Eli Lilly and Company
NEUTRAL
Price
$958.65
Market Cap
$858.01B
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
ITOC
--
LLY
41.7
Forward P/E
ITOC
--
LLY
22.78
P/B Ratio
ITOC
0.78
LLY
32.33
P/S Ratio
ITOC
13.23
LLY
13.16
EV/EBITDA
ITOC
-0.77
LLY
27.08

Profitability

Gross Margin
ITOC
62.59%
LLY
83.04%
Operating Margin
ITOC
-681.94%
LLY
44.9%
Profit Margin
ITOC
0.0%
LLY
31.67%
ROE
ITOC
-71.25%
LLY
101.16%
ROA
ITOC
-40.98%
LLY
19.41%

Growth

Revenue Growth
ITOC
91.6%
LLY
42.6%
Earnings Growth
ITOC
--
LLY
51.4%

Financial Health

Debt/Equity
ITOC
0.02
LLY
1.65
Current Ratio
ITOC
8.83
LLY
1.58
Quick Ratio
ITOC
6.95
LLY
0.78

Dividends

Dividend Yield
ITOC
--
LLY
0.68%
Payout Ratio
ITOC
0.0%
LLY
26.14%

AI Verdict

ITOC BEARISH

ITOC presents a high-risk profile characterized by a Piotroski F-Score of 4/9, indicating only marginal stability amidst a catastrophic price collapse. While the company shows strong top-line revenue growth (91.60%) and exceptional short-term liquidity (Current Ratio 8.83), these are completely overshadowed by an unsustainable operating margin of -681.94%. The stock has plummeted from a 52-week high of $32.00 to $0.28, reflecting a total loss of investor confidence and a severe technical breakdown.

Strengths
Strong YoY revenue growth of 91.60%
Very high liquidity with a Current Ratio of 8.83
Low leverage with a Debt/Equity ratio of 0.02
Risks
Extreme operational inefficiency (Operating Margin -681.94%)
Catastrophic price depreciation (99% drop from 52-week high)
Negative ROE (-71.25%) and ROA (-40.98%)
LLY NEUTRAL

LLY shows neutral fundamentals based on deterministic rules. Financial strength is weak (F-Score 3/9). Mixed signals with both opportunities and risks present.

Strengths
Strong profitability (31.7% margin)
Strong revenue growth of 42.6%
Strong ROE of 101.2%
Risks
High valuation with P/E of 41.7
Premium vs Graham Number ($123.85)
Weak financial trend (Piotroski F-Score: 3/9)

Compare Another Pair

ITOC vs LLY: Head-to-Head Comparison

This page compares iTonic Holdings Ltd. (ITOC) and Eli Lilly and Company (LLY) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile